##  [ASEAN Regulatory Strategy: Medical Devices](/index%2ephp/webinars/asean-regulatory-strategy-medical-devices) 

<a>Medical Devices</a>



<a>Past Webinar</a>



## **ASEAN Regulatory Strategy: Medical Devices**

**The webinar was successfully concluded on**

  **March 10, 2021.**

[Download Webinar](javascript:void(0))





We are delighted to see your interest in Freyr’s Webinar Series (FWS). The webinar on, **“ASEAN Regulatory Strategy: Medical Devices”,** was successfully concluded on March 10, 2021. Here is an archived version for your perusal.

## What Was It All About?

In a nutshell, the session, presented by our in-house Regulatory experts – Zulkhurnain Utar, Associate Director, RA - Malaysia and Rahul Verma, Senior Manager, Regulatory Strategy, focused on:

- Why Regulatory strategy must be part of corporate strategy?
- ASEAN Medtech Market and Regulatory scenario
- Factors influencing ASEAN Regulatory strategy
- Importance of country-specific Regulatory connect
- Freyr’s strategic framework
- Merging compliance with cost-effective strategic approach (includes, clinical, testing and QMS components)
- Key takeaways from the session

As a continuous practice, Freyr is destined to organize more webinar sessions related to Regulatory aspects of Life Sciences. We presume that you would like to be a part of all those sessions. If yes, let us have an opportunity to inform you about our next session.